Skip Navigation LinksHome > November/December 2013 - Volume 37 - Issue 6 > Scirrhous Hepatocellular Carcinoma on Gadoxetic Acid–Enhance...
Journal of Computer Assisted Tomography:
doi: 10.1097/RCT.0b013e31829d44c1
Gastrointestinal Imaging

Scirrhous Hepatocellular Carcinoma on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging: Emphasis on the Differentiation of Intrahepatic Cholangiocarcinoma

Park, Min Jung MD, PhD*†; Kim, Young Kon MD, PhD*†; Park, Hyun Jeong MD, PhD; Hwang, Jiyoung MD, PhD; Lee, Won Jae MD, PhD

Collapse Box

Abstract

Objective

The objective of this study was to determine the features of scirrhous hepatocellular carcinoma (sHCC) on gadoxetic acid–enhanced magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI) with an emphasis on the differentiation from intrahepatic cholangiocarcinoma (ICC).

Materials and Methods

A total of 41 patients with sHCCs and 41 patients with ICCs underwent gadoxetic acid–enhanced MRI and DWI. Images were analyzed for shape of lesions, surface retraction, enhancement pattern, proportion of arterial hyperenhancement, target appearance on the hepatobiliary phase and DWI, and presence of necrosis.

Results

Lobulating shape, rim enhancement, and target appearance on the hepatobiliary phase and DWI were the main features in both tumors. The proportion of arterial hyperenhancement of 20% of tumor diameter or more was the only significant MRI feature for differentiating sHCC from ICC (P ≤ 0.006 in the multivariate analysis).

Conclusions

Although the features of sHCC on gadoxetic acid–enhanced MRI and DWI are similar to those of ICC, the proportion of hyperenhancement of 20% or more on the arterial phase is a helpful feature in distinguishing sHCC from ICC.

Copyright © 2013 by Lippincott Williams & Wilkins

  

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.